Cynata Therapeutics Limited (ASX:CYP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0110
0.00 (0.00%)
Sep 18, 2026, 1:38 PM AEST

Cynata Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
3334532252
Market Cap Growth
-94.22%-89.94%-36.04%136.00%-56.47%-28.71%
Enterprise Value
212342625
Last Close Price
0.010.010.150.290.130.36

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-103.85103.85103.85103.85103.85
PS Ratio
1.561.9917.9822.8813.576.64
PB Ratio
-6.79-8.645.677.341.342.15
P/TBV Ratio
--5.677.341.342.15

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
1.040.4812.4118.063.653.19

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
2.282.28-0.84-0.86-0.97-0.99
Net Debt / EBITDA Ratio
0.120.120.540.621.114.11
Asset Turnover
0.400.400.240.170.070.28
Quick Ratio
0.550.554.245.397.309.23
Current Ratio
0.640.644.405.587.469.33
Return on Equity (ROE)
-325.34%-325.34%-142.29%-81.37%-70.17%-20.81%
Return on Assets (ROA)
-114.22%-114.22%-77.08%-46.70%-40.86%-13.42%
Return on Capital Employed (ROCE)
1982.30%1982.30%-160.70%-141.70%-89.00%-25.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-339.41%-266.68%-27.71%-18.39%-63.59%-10.56%
Buyback Yield / Dilution
-15.49%-15.49%-14.09%-23.80%-1.27%-9.85%